Literature DB >> 24993330

The importance of actual tumor growth rate on disease free survival and overall survival in laryngeal squamous cell carcinoma.

Liselotte W van Bockel1, Gerda M Verduijn2, Evelyn M Monninkhof3, Frank A Pameijer4, Chris H J Terhaard5.   

Abstract

BACKGROUND AND
PURPOSE: Evaluation of the variation in tumor growth rate and the influence of tumor growth rate on disease free survival (DFS) and overall survival (OS) in laryngeal squamous cell carcinoma (LSCC).
MATERIAL AND METHODS: We delineated tumor volume on a diagnostic and planning CT scan in 131 patients with laryngeal squamous cell carcinoma and calculated the tumor growth rate. Primary endpoint was DFS. Follow up data were collected retrospectively.
RESULTS: A large variation in tumor growth rate was seen. When dichotomized with a cut-off point of -0.3 ln(cc/day), we found a significant association between high growth rate and worse DFS (p = 0.008) and OS (p = 0.013). After stepwise adjustment for potential confounders (age, differentiation and tumor volume) this significant association persisted. However, after adjustment of N-stage association disappeared. Exploratory analyses suggested a strong association between N-stage and tumor growth rate.
CONCLUSIONS: In laryngeal squamous cell carcinoma, there is a large variation in tumor growth rate. This tumor growth rate seems to be an important factor in disease free survival and OS. This tumor growth rate is independent of age, differentiation and tumor volume associated with DFS, but N-stage seems to be a more important risk factor.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  DFS; Doubling time; Growth rate; Laryngeal carcinoma; OS; Outcome

Mesh:

Year:  2014        PMID: 24993330     DOI: 10.1016/j.radonc.2014.06.004

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  4 in total

1.  Specific growth rates calculated from CTs in patients with head and neck squamous cell carcinoma: a retrospective study performed in Austria.

Authors:  Daniel Dejaco; Teresa Steinbichler; Volker Hans Schartinger; Natalie Fischer; Maria Anegg; Joszef Dudas; Andrea Posch; Gerlig Widmann; Herbert Riechelmann
Journal:  BMJ Open       Date:  2019-02-19       Impact factor: 2.692

2.  Circular RNA ZNF609 promotes laryngeal squamous cell carcinoma progression by upregulating epidermal growth factor receptor via sponging microRNA-134-5p.

Authors:  Xiaoyan Yin; Jingmiao Wang; Chunguang Shan; Qiaojing Jia; Yanrui Bian; Haizhong Zhang
Journal:  Bioengineered       Date:  2022-03       Impact factor: 3.269

3.  Impact of delays in radiotherapy of head and neck cancer on outcome.

Authors:  Barbara Žumer; Maja Pohar Perme; Simona Jereb; Primož Strojan
Journal:  Radiat Oncol       Date:  2020-08-20       Impact factor: 3.481

4.  Impact of tumour growth rate during preceding treatment on tumour response to regorafenib or trifluridine/tipiracil in refractory metastatic colorectal cancer.

Authors:  Toshiki Masuishi; Hiroya Taniguchi; Takeshi Kawakami; Yasuyuki Kawamoto; Shigenori Kadowaki; Yusuke Onozawa; Tetsuhito Muranaka; Masahiro Tajika; Hirofumi Yasui; Hiroshi Nakatsumi; Satoshi Yuki; Kei Muro; Katsuhiro Omae; Yoshito Komatsu; Kentaro Yamazaki
Journal:  ESMO Open       Date:  2019-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.